Clinical data | |
---|---|
Other names | 4-Hydroxy-19-nortestosterone; 4,17β-Dihydroxyestr-4-en-3-one; 19-Norandrost-4-ene-4,17β-diol-3-one |
Routes of administration | Intramuscular injection (as oxabolone cipionate) |
Drug class | Androgen; Anabolic steroid |
Identifiers | |
IUPAC name
| |
CAS Number | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.022.920 |
Chemical and physical data | |
Formula | C18H26O3 |
Molar mass | 290.403 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Oxabolone is a synthetic anabolic-androgenic steroid (AAS) of the nandrolone (19-nortestosterone) group which was never marketed. It can be formulated as the cipionate ester prodrug oxabolone cipionate, which, in contrast, has been marketed for medical use.
Oxabolone is on the World Anti-Doping Agency's list of prohibited substances, and is therefore banned from use in most major sports.
The 17α-methylated analogue of oxabolone is methylhydroxynandrolone (4-hydroxy-17α-methyl-19-nortestosterone) and the 17α- and 19-methylated derivative of oxabolone is oxymesterone (4-hydroxy-17α-methyltestosterone).
References
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 908–. ISBN 978-1-4757-2085-3.
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 765–. ISBN 978-3-88763-075-1.
- ^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 211–. ISBN 978-94-011-4439-1.
- "The World Anti-Doping Code: The 2012 Prohibited List" (PDF). World Anti-Doping Agency. Archived from the original (PDF) on 2012-05-13. Retrieved 2012-07-17.
This article about a steroid is a stub. You can help Misplaced Pages by expanding it. |
This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it. |